Intra-Cellular Therapies Reports Second Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales Guidance

Go back to Intra-Cellular Therapies Reports Second Quarter 2023 Financial Results and Raises 2023 CAPLYTA Sales Guidance
INTRA-CELL THRP (NASDAQ: ITCI) Delayed: 131.87 --0 (-0%)
Previous Close $131.87    52 Week High $59.96 
Open $131.87    52 Week Low $10.80 
Day High $131.87    P/E N/A 
Day Low $131.87    EPS $0.00 
Volume 29,617